Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

Background. Early diagnosis and treatment are crucial in invasive fungal diseases (IFD). Serum (1-3)-β-d-glucan (BG) is believed to be an early IFD marker, but its diagnostic performance has been ambiguous, with insufficient data regarding sensitivity at the time of IFD diagnosis (TOD) and according...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Angebault, Cécile, Lanternier, Fanny, Dalle, Frédéric, Schrimpf, Cécile, Roupie, Anne-Laure, Dupuis, Aurélie, Agathine, Aurélie, Scemla, Anne, Paubelle, Etienne, Caillot, Denis, Neven, Bénédicte, Frange, Pierre, Suarez, Felipe, d'Enfert, Christophe, Lortholary, Olivier, Bougnoux, Marie-Elisabeth
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942764/
https://ncbi.nlm.nih.gov/pubmed/27419189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars